Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.92−2.76 (-16.55%)
Close on Nov 17, 2026Market cap $1.01BP/E –Yield –
Omeros total assets
Total assets on the balance sheet at the end of each period.
Omeros's total assets was $286.83M at Jun 30, 2026. For fiscal 2025 it was $325.63M, up 17.5% from the year before. Over ten years it grew 20.9% a year on average. The highest annual figure on record is $590.97M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $325.63M | +17.5% |
| FY2024 | Dec 31, 2024 | $277.08M | -26.8% |
| FY2023 | Dec 31, 2023 | $378.27M | -36.0% |
| FY2022 | Dec 31, 2022 | $590.97M | +41.0% |
| FY2021 | Dec 31, 2021 | $419.27M | +131.6% |
| FY2020 | Dec 31, 2020 | $181.04M | +32.2% |
| FY2019 | Dec 31, 2019 | $136.97M | +42.8% |
| FY2018 | Dec 31, 2018 | $95.94M | -17.5% |
| FY2017 | Dec 31, 2017 | $116.33M | +72.9% |
| FY2016 | Dec 31, 2016 | $67.28M | +37.3% |
| FY2015 | Dec 31, 2015 | $49.00M | +352.2% |
| FY2014 | Dec 31, 2014 | $10.83M | -34.5% |
| FY2013 | Dec 31, 2013 | $16.54M | -37.8% |
| FY2012 | Dec 31, 2012 | $26.58M | -1.5% |
| FY2011 | Dec 31, 2011 | $26.98M | -41.0% |
| FY2010 | Dec 31, 2010 | $45.70M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $286.83M | +43.0% |
| Q1 FY2026 | Mar 31, 2026 | $286.17M | +21.7% |
| Q4 FY2025 | Dec 31, 2025 | $325.63M | +17.5% |
| Q3 FY2025 | Sep 30, 2025 | $185.71M | -40.7% |
| Q2 FY2025 | Jun 30, 2025 | $200.57M | -43.7% |
| Q1 FY2025 | Mar 31, 2025 | $235.16M | -46.2% |
| Q4 FY2024 | Dec 31, 2024 | $277.08M | -26.8% |
| Q3 FY2024 | Sep 30, 2024 | $313.34M | -36.5% |
| Q2 FY2024 | Jun 30, 2024 | $356.31M | -32.4% |
| Q1 FY2024 | Mar 31, 2024 | $437.49M | -21.9% |
| Q4 FY2023 | Dec 31, 2023 | $378.27M | -36.0% |
| Q3 FY2023 | Sep 30, 2023 | $493.07M | +7.8% |
| Q2 FY2023 | Jun 30, 2023 | $527.42M | +52.6% |
| Q1 FY2023 | Mar 31, 2023 | $560.13M | +51.7% |
| Q4 FY2022 | Dec 31, 2022 | $590.97M | +41.0% |
| Q3 FY2022 | Sep 30, 2022 | $457.55M | +270.7% |
| Q2 FY2022 | Jun 30, 2022 | $345.64M | +114.1% |
| Q1 FY2022 | Mar 31, 2022 | $369.26M | +104.0% |
| Q4 FY2021 | Dec 31, 2021 | $419.27M | +84.6% |
| Q3 FY2021 | Sep 30, 2021 | $123.43M | +74.6% |
| Q1 FY2021 | Mar 31, 2021 | $161.44M | +36.6% |
| Q4 FY2020 | Dec 31, 2020 | $181.04M | +32.2% |
| Q3 FY2020 | Sep 30, 2020 | $227.08M | +148.8% |
| Q2 FY2020 | Jun 30, 2020 | $70.69M | -21.2% |
| Q1 FY2020 | Mar 31, 2020 | $118.21M | +16.8% |
| Q4 FY2019 | Dec 31, 2019 | $136.97M | +42.8% |
| Q3 FY2019 | Sep 30, 2019 | $91.26M | +20.7% |
| Q2 FY2019 | Jun 30, 2019 | $89.76M | -15.6% |
| Q1 FY2019 | Mar 31, 2019 | $101.25M | +13.7% |
| Q4 FY2018 | Dec 31, 2018 | $95.94M | -17.5% |
| Q3 FY2018 | Sep 30, 2018 | $75.61M | -39.8% |
| Q2 FY2018 | Jun 30, 2018 | $106.35M | +76.2% |
| Q1 FY2018 | Mar 31, 2018 | $89.04M | +52.4% |
| Q4 FY2017 | Dec 31, 2017 | $116.33M | +72.9% |
| Q3 FY2017 | Sep 30, 2017 | $125.52M | +72.5% |
| Q2 FY2017 | Jun 30, 2017 | $60.35M | +30.9% |
| Q1 FY2017 | Mar 31, 2017 | $58.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $67.28M | – |
| Q3 FY2016 | Sep 30, 2016 | $72.76M | – |
| Q2 FY2016 | Jun 30, 2016 | $46.11M | – |
See a number that looks wrong?